|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.7 TWD | +0.74% |
|
-2.17% | -15.45% |
| 03-14 | Panion & Bf Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-07 | Panion & Bf Biotech Inc. Approves Cash Dividend for 2023 | CI |
Panion & Bf Biotech Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 1,901.21 million compared to TWD 1,568.64 million a year ago. Net income was TWD 104.4 million compared to TWD 27.9 million a year ago.
Basic earnings per share from continuing operations was TWD 1.32 compared to TWD 0.36 a year ago. Diluted earnings per share from continuing operations was TWD 1.32 compared to TWD 0.36 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.45% | 248M | |
| +29.98% | 684B | |
| +30.34% | 568B | |
| -3.52% | 361B | |
| +18.59% | 329B | |
| +4.07% | 284B | |
| +16.21% | 240B | |
| +9.66% | 208B | |
| -6.83% | 200B | |
| +7.09% | 166B |
PANION & BF BIOTECH INC. 